|
市場調查報告書
女性健康系列：口服避孕藥如何改變了市場呢
Women's Health Series: How Have New Oral Contraceptives Changed the Market?
|
女性健康系列：口服避孕藥如何改變了市場呢 是由出版商Decision Resources, Inc.在2008年09月所出版的。
這份英文市場調查報告書價格從美金4500起跳。
此報告書彙整了口服避孕藥的概要與處方藥品牌、行銷促銷活動與產品導入、新興藥劑動向、未來的市場前景洞察等。報告書之內容摘要如下所示。
摘要
說明
口服避孕藥的概要
一般處方的品牌藥
- Bayer的Yasmin 28以及Yaz
- Warner Chilcott的Loestrin 24 Fe
- Ortho-McNeil/Janssen的OrthoCyclen/Ortho Tri-Cyclen/Ortho Tri-Cyclen Lo
- Duramed的Seasonale/Seasonique
美國醫師的處方型態
針對患者的行銷以及直接對顧客廣告的影響
新興的口服避孕藥
市場前景洞察
Abstract
Introduction
- The oral contraceptive market is mature, with a high level of competition
and a stable patient population. Dozens of oral contraceptives are available
worldwide; most are comparable in terms of effi cacy in their primary
indication (preventing pregnancy) and safety. As a result, drug developers
have implemented a variety of strategies to differentiate their products from
one another, including aggressive and expensive direct-toconsumer (DTC)
marketing campaigns and the pursuit of new approvals for additional
indications.
Get the Answers You Need to Shape Your Strategy
- Oral contraceptives have been available for more than 40 years and are the
most popular form of prescription birth control. What types of oral
contraceptives are available? What are physicians' preferred brands? What
brands do patients specifi cally request?
- Oral contraceptives can be implemented for uses beyond the prevention of
pregnancy. What other indications are oral contraceptives often prescribed to
treat? What agents have received approval for multiple indications? What
percentage of patients use oral contraceptives for reasons other than birth
control?
- The drugs' similarity in effi cacy and safety has forced drug
manufacturers to fi nd other methods of establishing a competitive position.
What attributes are companies highlighting to differentiate their products?
How does DTC advertising factor into a product' s adoption in the market?
Scope
- Specialist opinions: obstetricians/gynecologists were surveyed to
determine their opinions on current and emerging contraceptives.
- Overview of oral contraceptives: the menstrual cycle, estrogen/progestin
oral contraceptives, progestin-only oral contraceptives.
- Commonly prescribed brands: Bayer' s Yaz and Yasmin, Warner Chilcott' s
Loestrin 24 Fe, Ortho- McNeil/Janssen' s Ortho Tri-Cyclen and Ortho Tri-Cyclen
Lo, Barr Pharmaceuticals' Seasonale and Seasonique.
- Marketing campaigns and product adoption: analysis of the effect of
promotional spend, including DTC advertising, on the uptake of a new product.
- Emerging agents: Schering-Plough' s NOMAC/E2 and Duramed' s DR-1021.
- Outlook for the oral contraceptive market: 2007 sales, impact of new birth
control methods, drivers and constraints of market growth.
- Women' s Health Series: in 2007, the market for women' s reproductive health
exceeded $23 billion worldwide. In the Women' s Health Series, we examine three
specifi c markets, focusing on areas of unmet need and the best marketing
strategies to ensure adoption of a new agent. We provide insight from a
variety of thought leaders on the current state of disease treatment and their
opinions on the most promising agents currently in the pipeline.
Mentioned in This Spectrum Report
- Akzo Nobel
- Barr Pharmaceuticals
- Bayer
- Duramed
- Janssen
- Johnson & Johnson
- Organon
- Ortho-McNeil
- Pfi zer
- Schering-Plough
- Warner Chilcott
- Watson Pharmaceuticals
- Wyeth
Table of Contents
Executive Summary
- Strategic Considerations
- Stakeholder Implications
Introduction
Overview of Oral Contraception
- Normal Menstrual Cycle
- Types of Oral Contraceptives
- Combination Estrogen/Progestin Pills
- Progestin Pills
Commonly Prescribed Branded Oral Contraceptive Agents
- Bayer' s Yasmin 28 and Yaz
- Warner Chilcott' s Loestrin 24 Fe
- Ortho-McNeil/Janssen' s OrthoCyclen/Ortho Tri-Cyclen/Ortho Tri-Cyclen Lo
- Duramed' s Seasonale/Seasonique
Prescribing Patterns of U.S. Physicians
Effect of Marketing and Direct-to-Consumer Advertising on Patient Share
Emerging Oral Contraceptive Agents
Outlook for the Oral Contraceptives Market
Tables
- 1. Types of Hormonal Contraceptive Treatments
- 2. Commonly Prescribed Branded Oral Contraceptives
- 3. U.S. and Worldwide Oral Contraceptive Sales, 2007
Figures
- 1. Specialists' Estimates of Patient Share of Prescription Contraceptives,
by Type
- 2. Survey Question: What Percentages of Patients Take Oral Contraceptives
- for These Stated Reasons?
- 3. Survey Question: Please Rank Your First, Second, and Third Preference
- for Oral Contraceptive
- 4. Survey Question: How Often Do You Comply with a Patient' s Request for
- a Specifi c Oral Contraceptive Brand?
- 5. Promotional Spend and New Prescriptions of Ortho Tri-Cyclen Lo,
2003-2007
- 6. Promotional Spend and New Prescriptions of Yasmin 28, 2003-2007
- 7. Survey Question: What Percentage of Your Patients Request the Following
Brands
- 8. Worldwide Oral Contraceptive Sales, 1998-2007
- 9. Worldwide Oral Contraceptive Market Share, 2007
- 10. U.S. Oral Contraceptive Market Share, 2007
|
